Global Bipolar Disorder Market Research Report 2026(Status and Outlook)

May 2026 | 134 pages | ID: G2B587857F26EN
Bosson Research

Abstracts

Bipolar disorder (formerly called manic-depressive illness or manic depression) is a mental disorder that causes unusual shifts in mood, energy, activity levels, concentration, and the ability to carry out day-to-day tasks.

The global Bipolar Disorder market size was estimated at USD 6103.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 2.70% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Bipolar Disorder market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Bipolar Disorder market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Bipolar Disorder market.

Global Bipolar Disorder Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• Glaxo SmithKline (GSK)
• Pfizer Inc.
• Janssen Pharmaceuticals
• Eli Lilly
• Allergan Plc.
• Novartis AG
• AbbVie Inc.
• Otsuka Holdings Ltd
• AstraZeneca

Market Segmentation (by Type)

• Bipolar I Disorder
• Bipolar II Disorder
• Cyclothymic Disorder

Market Segmentation (by Application)

• Mood Stabilizers
• Anticonvulsants
• Antipsychotic drugs
• Antidepressant drugs
• Antianxiety drugs
• Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Bipolar Disorder Market

Overview of the regional outlook of the Bipolar Disorder Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Bipolar Disorder Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Bipolar Disorder, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Bipolar Disorder
1.2 Key Market Segments
  1.2.1 Bipolar Disorder Segment by Type
  1.2.2 Bipolar Disorder Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 BIPOLAR DISORDER MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Bipolar Disorder Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Bipolar Disorder Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 BIPOLAR DISORDER MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Bipolar Disorder Product Life Cycle
3.3 Global Bipolar Disorder Sales by Manufacturers (2020-2025)
3.4 Global Bipolar Disorder Revenue Market Share by Manufacturers (2020-2025)
3.5 Bipolar Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Bipolar Disorder Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Bipolar Disorder Market Competitive Situation and Trends
  3.8.1 Bipolar Disorder Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Bipolar Disorder Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 BIPOLAR DISORDER INDUSTRY CHAIN ANALYSIS

4.1 Bipolar Disorder Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF BIPOLAR DISORDER MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Bipolar Disorder Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Bipolar Disorder Market
5.7 ESG Ratings of Leading Companies

6 BIPOLAR DISORDER MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Bipolar Disorder Sales Market Share by Type (2020-2025)
6.3 Global Bipolar Disorder Market Size by Type (2020-2025)
6.4 Global Bipolar Disorder Price by Type (2020-2025)

7 BIPOLAR DISORDER MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Bipolar Disorder Market Sales by Application (2020-2025)
7.3 Global Bipolar Disorder Market Size (M USD) by Application (2020-2025)
7.4 Global Bipolar Disorder Sales Growth Rate by Application (2020-2025)

8 BIPOLAR DISORDER MARKET SALES BY REGION

8.1 Global Bipolar Disorder Sales by Region
  8.1.1 Global Bipolar Disorder Sales by Region
  8.1.2 Global Bipolar Disorder Sales Market Share by Region
8.2 Global Bipolar Disorder Market Size by Region
  8.2.1 Global Bipolar Disorder Market Size by Region
  8.2.2 Global Bipolar Disorder Market Size by Region
8.3 North America
  8.3.1 North America Bipolar Disorder Sales by Country
  8.3.2 North America Bipolar Disorder Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Bipolar Disorder Sales by Country
  8.4.2 Europe Bipolar Disorder Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Bipolar Disorder Sales by Region
  8.5.2 Asia Pacific Bipolar Disorder Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Bipolar Disorder Sales by Country
  8.6.2 South America Bipolar Disorder Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Bipolar Disorder Sales by Region
  8.7.2 Middle East and Africa Bipolar Disorder Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 BIPOLAR DISORDER MARKET PRODUCTION BY REGION

9.1 Global Production of Bipolar Disorder by Region(2020-2025)
9.2 Global Bipolar Disorder Revenue Market Share by Region (2020-2025)
9.3 Global Bipolar Disorder Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Bipolar Disorder Production
  9.4.1 North America Bipolar Disorder Production Growth Rate (2020-2025)
  9.4.2 North America Bipolar Disorder Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Bipolar Disorder Production
  9.5.1 Europe Bipolar Disorder Production Growth Rate (2020-2025)
  9.5.2 Europe Bipolar Disorder Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Bipolar Disorder Production (2020-2025)
  9.6.1 Japan Bipolar Disorder Production Growth Rate (2020-2025)
  9.6.2 Japan Bipolar Disorder Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Bipolar Disorder Production (2020-2025)
  9.7.1 China Bipolar Disorder Production Growth Rate (2020-2025)
  9.7.2 China Bipolar Disorder Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Glaxo SmithKline (GSK)
  10.1.1 Glaxo SmithKline (GSK) Basic Information
  10.1.2 Glaxo SmithKline (GSK) Bipolar Disorder Product Overview
  10.1.3 Glaxo SmithKline (GSK) Bipolar Disorder Product Market Performance
  10.1.4 Glaxo SmithKline (GSK) Business Overview
  10.1.5 Glaxo SmithKline (GSK) SWOT Analysis
  10.1.6 Glaxo SmithKline (GSK) Recent Developments
10.2 Pfizer Inc.
  10.2.1 Pfizer Inc. Basic Information
  10.2.2 Pfizer Inc. Bipolar Disorder Product Overview
  10.2.3 Pfizer Inc. Bipolar Disorder Product Market Performance
  10.2.4 Pfizer Inc. Business Overview
  10.2.5 Pfizer Inc. SWOT Analysis
  10.2.6 Pfizer Inc. Recent Developments
10.3 Janssen Pharmaceuticals
  10.3.1 Janssen Pharmaceuticals Basic Information
  10.3.2 Janssen Pharmaceuticals Bipolar Disorder Product Overview
  10.3.3 Janssen Pharmaceuticals Bipolar Disorder Product Market Performance
  10.3.4 Janssen Pharmaceuticals Business Overview
  10.3.5 Janssen Pharmaceuticals SWOT Analysis
  10.3.6 Janssen Pharmaceuticals Recent Developments
10.4 Eli Lilly
  10.4.1 Eli Lilly Basic Information
  10.4.2 Eli Lilly Bipolar Disorder Product Overview
  10.4.3 Eli Lilly Bipolar Disorder Product Market Performance
  10.4.4 Eli Lilly Business Overview
  10.4.5 Eli Lilly Recent Developments
10.5 Allergan Plc.
  10.5.1 Allergan Plc. Basic Information
  10.5.2 Allergan Plc. Bipolar Disorder Product Overview
  10.5.3 Allergan Plc. Bipolar Disorder Product Market Performance
  10.5.4 Allergan Plc. Business Overview
  10.5.5 Allergan Plc. Recent Developments
10.6 Novartis AG
  10.6.1 Novartis AG Basic Information
  10.6.2 Novartis AG Bipolar Disorder Product Overview
  10.6.3 Novartis AG Bipolar Disorder Product Market Performance
  10.6.4 Novartis AG Business Overview
  10.6.5 Novartis AG Recent Developments
10.7 AbbVie Inc.
  10.7.1 AbbVie Inc. Basic Information
  10.7.2 AbbVie Inc. Bipolar Disorder Product Overview
  10.7.3 AbbVie Inc. Bipolar Disorder Product Market Performance
  10.7.4 AbbVie Inc. Business Overview
  10.7.5 AbbVie Inc. Recent Developments
10.8 Otsuka Holdings Ltd
  10.8.1 Otsuka Holdings Ltd Basic Information
  10.8.2 Otsuka Holdings Ltd Bipolar Disorder Product Overview
  10.8.3 Otsuka Holdings Ltd Bipolar Disorder Product Market Performance
  10.8.4 Otsuka Holdings Ltd Business Overview
  10.8.5 Otsuka Holdings Ltd Recent Developments
10.9 AstraZeneca
  10.9.1 AstraZeneca Basic Information
  10.9.2 AstraZeneca Bipolar Disorder Product Overview
  10.9.3 AstraZeneca Bipolar Disorder Product Market Performance
  10.9.4 AstraZeneca Business Overview
  10.9.5 AstraZeneca Recent Developments

11 BIPOLAR DISORDER MARKET FORECAST BY REGION

11.1 Global Bipolar Disorder Market Size Forecast
11.2 Global Bipolar Disorder Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Bipolar Disorder Market Size Forecast by Country
  11.2.3 Asia Pacific Bipolar Disorder Market Size Forecast by Region
  11.2.4 South America Bipolar Disorder Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Bipolar Disorder by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Bipolar Disorder Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Bipolar Disorder by Type (2026-2035)
  12.1.2 Global Bipolar Disorder Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Bipolar Disorder by Type (2026-2035)
12.2 Global Bipolar Disorder Market Forecast by Application (2026-2035)
  12.2.1 Global Bipolar Disorder Sales (K Units) Forecast by Application
  12.2.2 Global Bipolar Disorder Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Bipolar Disorder Market Size by Type (M USD)
Table 4. Global Bipolar Disorder Market Size by Application
Table 5. Bipolar Disorder Market Size Comparison by Region (M USD)
Table 6. Global Bipolar Disorder Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Bipolar Disorder Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Bipolar Disorder Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Bipolar Disorder Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bipolar Disorder as of 2025)
Table 11. Global Market Bipolar Disorder Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Bipolar Disorder Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Bipolar Disorder Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Bipolar Disorder Sales by Type (K Units)
Table 27. Global Bipolar Disorder Market Size by Type (M USD)
Table 28. Global Bipolar Disorder Sales (K Units) by Type (2020-2025)
Table 29. Global Bipolar Disorder Sales Market Share by Type (2020-2025)
Table 30. Global Bipolar Disorder Market Size (M USD) by Type (2020-2025)
Table 31. Global Bipolar Disorder Market Share by Type (2020-2025)
Table 32. Global Bipolar Disorder Price (USD/Unit) by Type (2020-2025)
Table 33. Global Bipolar Disorder Sales (K Units) by Application
Table 34. Global Bipolar Disorder Market Size by Application
Table 35. Global Bipolar Disorder Sales by Application (2020-2025) & (K Units)
Table 36. Global Bipolar Disorder Sales Market Share by Application (2020-2025)
Table 37. Global Bipolar Disorder Market Size by Application (2020-2025) & (M USD)
Table 38. Global Bipolar Disorder Market Share by Application (2020-2025)
Table 39. Global Bipolar Disorder Sales Growth Rate by Application (2020-2025)
Table 40. Global Bipolar Disorder Sales by Region (2020-2025) & (K Units)
Table 41. Global Bipolar Disorder Sales Market Share by Region (2020-2025)
Table 42. Global Bipolar Disorder Market Size by Region (2020-2025) & (M USD)
Table 43. Global Bipolar Disorder Market Size by Region (2020-2025)
Table 44. North America Bipolar Disorder Sales by Country (2020-2025) & (K Units)
Table 45. North America Bipolar Disorder Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Bipolar Disorder Sales by Country (2020-2025) & (K Units)
Table 47. Europe Bipolar Disorder Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Bipolar Disorder Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Bipolar Disorder Market Size by Region (2020-2025) & (M USD)
Table 50. South America Bipolar Disorder Sales by Country (2020-2025) & (K Units)
Table 51. South America Bipolar Disorder Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Bipolar Disorder Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Bipolar Disorder Market Size by Region (2020-2025) & (M USD)
Table 54. Global Bipolar Disorder Production (K Units) by Region(2020-2025)
Table 55. Global Bipolar Disorder Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Bipolar Disorder Revenue Market Share by Region (2020-2025)
Table 57. Global Bipolar Disorder Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Bipolar Disorder Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Bipolar Disorder Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Bipolar Disorder Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Bipolar Disorder Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Glaxo SmithKline (GSK) Basic Information
Table 63. Glaxo SmithKline (GSK) Bipolar Disorder Product Overview
Table 64. Glaxo SmithKline (GSK) Bipolar Disorder Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Glaxo SmithKline (GSK) Business Overview
Table 66. Glaxo SmithKline (GSK) SWOT Analysis
Table 67. Glaxo SmithKline (GSK) Recent Developments
Table 68. Pfizer Inc. Basic Information
Table 69. Pfizer Inc. Bipolar Disorder Product Overview
Table 70. Pfizer Inc. Bipolar Disorder Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Pfizer Inc. Business Overview
Table 72. Pfizer Inc. SWOT Analysis
Table 73. Pfizer Inc. Recent Developments
Table 74. Janssen Pharmaceuticals Basic Information
Table 75. Janssen Pharmaceuticals Bipolar Disorder Product Overview
Table 76. Janssen Pharmaceuticals Bipolar Disorder Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Janssen Pharmaceuticals Business Overview
Table 78. Janssen Pharmaceuticals SWOT Analysis
Table 79. Janssen Pharmaceuticals Recent Developments
Table 80. Eli Lilly Basic Information
Table 81. Eli Lilly Bipolar Disorder Product Overview
Table 82. Eli Lilly Bipolar Disorder Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Eli Lilly Business Overview
Table 84. Eli Lilly Recent Developments
Table 85. Allergan Plc. Basic Information
Table 86. Allergan Plc. Bipolar Disorder Product Overview
Table 87. Allergan Plc. Bipolar Disorder Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Allergan Plc. Business Overview
Table 89. Allergan Plc. Recent Developments
Table 90. Novartis AG Basic Information
Table 91. Novartis AG Bipolar Disorder Product Overview
Table 92. Novartis AG Bipolar Disorder Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Novartis AG Business Overview
Table 94. Novartis AG Recent Developments
Table 95. AbbVie Inc. Basic Information
Table 96. AbbVie Inc. Bipolar Disorder Product Overview
Table 97. AbbVie Inc. Bipolar Disorder Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. AbbVie Inc. Business Overview
Table 99. AbbVie Inc. Recent Developments
Table 100. Otsuka Holdings Ltd Basic Information
Table 101. Otsuka Holdings Ltd Bipolar Disorder Product Overview
Table 102. Otsuka Holdings Ltd Bipolar Disorder Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Otsuka Holdings Ltd Business Overview
Table 104. Otsuka Holdings Ltd Recent Developments
Table 105. AstraZeneca Basic Information
Table 106. AstraZeneca Bipolar Disorder Product Overview
Table 107. AstraZeneca Bipolar Disorder Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. AstraZeneca Business Overview
Table 109. AstraZeneca Recent Developments
Table 110. Global Bipolar Disorder Sales Forecast by Region (2026-2035) & (K Units)
Table 111. Global Bipolar Disorder Market Size Forecast by Region (2026-2035) & (M USD)
Table 112. North America Bipolar Disorder Sales Forecast by Country (2026-2035) & (K Units)
Table 113. North America Bipolar Disorder Market Size Forecast by Country (2026-2035) & (M USD)
Table 114. Europe Bipolar Disorder Sales Forecast by Country (2026-2035) & (K Units)
Table 115. Europe Bipolar Disorder Market Size Forecast by Country (2026-2035) & (M USD)
Table 116. Asia Pacific Bipolar Disorder Sales Forecast by Region (2026-2035) & (K Units)
Table 117. Asia Pacific Bipolar Disorder Market Size Forecast by Region (2026-2035) & (M USD)
Table 118. South America Bipolar Disorder Sales Forecast by Country (2026-2035) & (K Units)
Table 119. South America Bipolar Disorder Market Size Forecast by Country (2026-2035) & (M USD)
Table 120. Middle East and Africa Bipolar Disorder Sales Forecast by Country (2026-2035) & (Units)
Table 121. Middle East and Africa Bipolar Disorder Market Size Forecast by Country (2026-2035) & (M USD)
Table 122. Global Bipolar Disorder Sales Forecast by Type (2026-2035) & (K Units)
Table 123. Global Bipolar Disorder Market Size Forecast by Type (2026-2035) & (M USD)
Table 124. Global Bipolar Disorder Price Forecast by Type (2026-2035) & (USD/Unit)
Table 125. Global Bipolar Disorder Sales (K Units) Forecast by Application (2026-2035)
Table 126. Global Bipolar Disorder Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Bipolar Disorder
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Bipolar Disorder Market Size (M USD), 2025-2035
Figure 5. Global Bipolar Disorder Market Size (M USD) (2020-2035)
Figure 6. Global Bipolar Disorder Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Bipolar Disorder Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Bipolar Disorder Product Life Cycle
Figure 13. Bipolar Disorder Sales Share by Manufacturers in 2025
Figure 14. Global Bipolar Disorder Revenue Share by Manufacturers in 2025
Figure 15. Bipolar Disorder Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Bipolar Disorder Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Bipolar Disorder Revenue in 2025
Figure 18. Industry Chain Map of Bipolar Disorder
Figure 19. Global Bipolar Disorder Market PEST Analysis
Figure 20. Global Bipolar Disorder Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Bipolar Disorder Market Share by Type
Figure 27. Sales Market Share of Bipolar Disorder by Type (2020-2025)
Figure 28. Sales Market Share of Bipolar Disorder by Type in 2025
Figure 29. Market Share of Bipolar Disorder by Type (2020-2025)
Figure 30. Market Share of Bipolar Disorder by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Bipolar Disorder Market Share by Application
Figure 33. Global Bipolar Disorder Sales Market Share by Application (2020-2025)
Figure 34. Global Bipolar Disorder Sales Market Share by Application in 2025
Figure 35. Global Bipolar Disorder Market Share by Application (2020-2025)
Figure 36. Global Bipolar Disorder Market Share by Application in 2025
Figure 37. Global Bipolar Disorder Sales Growth Rate by Application (2020-2025)
Figure 38. Global Bipolar Disorder Sales Market Share by Region (2020-2025)
Figure 39. Global Bipolar Disorder Market Size by Region (2020-2025)
Figure 40. North America Bipolar Disorder Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Bipolar Disorder Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Bipolar Disorder Sales Market Share by Country in 2024
Figure 43. North America Bipolar Disorder Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Bipolar Disorder Market Size by Country in 2024
Figure 45. U.S. Bipolar Disorder Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Bipolar Disorder Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Bipolar Disorder Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Bipolar Disorder Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Bipolar Disorder Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Bipolar Disorder Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Bipolar Disorder Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Bipolar Disorder Sales Market Share by Country in 2024
Figure 53. Europe Bipolar Disorder Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Bipolar Disorder Market Size by Country in 2024
Figure 55. Germany Bipolar Disorder Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Bipolar Disorder Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Bipolar Disorder Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Bipolar Disorder Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Bipolar Disorder Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Bipolar Disorder Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Bipolar Disorder Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Bipolar Disorder Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Bipolar Disorder Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Bipolar Disorder Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Bipolar Disorder Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Bipolar Disorder Sales Market Share by Region in 2024
Figure 67. Asia Pacific Bipolar Disorder Market Size by Region in 2024
Figure 68. China Bipolar Disorder Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Bipolar Disorder Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Bipolar Disorder Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Bipolar Disorder Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Bipolar Disorder Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Bipolar Disorder Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Bipolar Disorder Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Bipolar Disorder Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Bipolar Disorder Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Bipolar Disorder Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Bipolar Disorder Sales and Growth Rate (K Units)
Figure 79. South America Bipolar Disorder Sales Market Share by Country in 2024
Figure 80. South America Bipolar Disorder Market Size and Growth Rate (M USD)
Figure 81. South America Bipolar Disorder Market Size by Country in 2024
Figure 82. Brazil Bipolar Disorder Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Bipolar Disorder Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Bipolar Disorder Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Bipolar Disorder Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Bipolar Disorder Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Bipolar Disorder Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Bipolar Disorder Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Bipolar Disorder Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Bipolar Disorder Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Bipolar Disorder Market Size by Region in 2024
Figure 92. Saudi Arabia Bipolar Disorder Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Bipolar Disorder Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Bipolar Disorder Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Bipolar Disorder Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Bipolar Disorder Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Bipolar Disorder Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Bipolar Disorder Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Bipolar Disorder Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Bipolar Disorder Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Bipolar Disorder Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Bipolar Disorder Production Market Share by Region (2020-2025)
Figure 103. North America Bipolar Disorder Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Bipolar Disorder Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Bipolar Disorder Production (K Units) Growth Rate (2020-2025)
Figure 106. China Bipolar Disorder Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Bipolar Disorder Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Bipolar Disorder Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Bipolar Disorder Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Bipolar Disorder Market Share Forecast by Type (2026-2035)
Figure 111. Global Bipolar Disorder Sales Forecast by Application (2026-2035)
Figure 112. Global Bipolar Disorder Market Share Forecast by Application (2026-2035)